SDI

SDI Equity Growth

Delisted

The Year-over-Year Equity Growth of SDI (SDI.AX) as of Oct 28, 2026 is 9.26 %. In the previous year, Year-over-Year Equity Growth was 6.89 % — a change of 34.35% (higher).

Equity Growth

9.26 %

YoY

34.35%

Last updated:

Year-over-Year Equity Growth of SDI is 2025 9.26 % . Year-over-Year Equity Growth of SDI was 2024 6.89 % . It decreases by 34.35% higher compared to the previous year.

The SDI Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2018
4.84 AUD
Jan 1, 2019
5.08 AUD
Jan 1, 2020
0.96 AUD
Jan 1, 2021
8.12 AUD
Jan 1, 2022
4.96 AUD
Jan 1, 2023
4.99 AUD
Jan 1, 2024
6.89 AUD
Jan 1, 2025
9.26 AUD
The SDI Equity Growth history
YEAREquity GrowthYoY
9.26 %+34.35%
6.89 %+37.97%
4.99 %+0.77%
4.96 %-38.95%
8.12 %+741.53%
0.96 %-81.00%
5.08 %+4.89%
4.84 %+20.39%
4.02 %-58.94%
9.79 %-15.24%
11.55 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

SDI Stock analysis

What does SDI do? SDI Ltd is a British company specializing in the development and manufacture of scientific and medical devices. The company was founded by John Poulter in 1952 and is headquartered in Basingstoke, Hampshire. The history of SDI Ltd began with the development of scientific measuring devices, particularly instruments for measuring optical signals. Over the years, the company has specialized in the development of devices for medical diagnostics and therapy. SDI Ltd now operates in various areas. One of its main business fields is microbiology and infection prevention. The company offers a wide range of products including test systems for infectious diseases such as HIV, Hepatitis B and C, tuberculosis, and malaria. Another business field of SDI Ltd is the development of devices for the diagnosis of cancer and other diseases. The company offers both instruments for tissue sampling as well as automated diagnostic systems. SDI Ltd is also active in medical technology and offers a wide range of products, from simple instruments like thermal thermometers to complex surgical instruments and implants. In addition to medical diagnostics and therapy, SDI Ltd is also active in the field of analytical technology. The company offers instruments for chemical analysis, environmental monitoring, and food sampling. The business model of SDI Ltd is based on the development and manufacture of high-quality and reliable devices for scientific, medical, and industrial use. The company relies on close collaboration with customers and partners to provide innovative solutions for the challenges of modern science and medicine. An important part of SDI Ltd's business model is research and development. The company invests a significant portion of its revenue in the development of new products and technologies to always offer its customers the latest and best solutions. Overall, SDI Ltd has established itself as a leading company in the field of scientific and medical devices. The company has a long history of successful product developments and is known for its high quality, reliability, and innovation. With its wide range of products and its commitment to research and development, SDI Ltd is well-equipped to continue playing an important role in science and medicine in the future. SDI is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SDI stock

Year-over-Year Equity Growth of SDI is 9.26 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth SDI since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's SDI historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Growth — SDI

Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth

All Key Metrics — SDI